Post-mortem Studies of Dopaminergic Function in Schizophrenia
- 1 January 1986
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- [3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsyEuropean Journal of Pharmacology, 1984
- Dopamine-D-1 and D-2 receptors in Huntington's diseaseEuropean Journal of Pharmacology, 1983
- VI. The concurrent estimation of the major monoamine metabolites in human and non-human primate brain by HPLC with fluorescence and electrochemical detectionLife Sciences, 1981
- Molecular pathology of schizophrenia: more than one disease process?BMJ, 1980
- Antipsychotic Drug Action in Schizophrenic Patients: Effect on Cortical Dopamine Metabolism After Long-Term TreatmentScience, 1979
- Monoamine Mechanisms in Chronic Schizophrenia: Post-Mortem Neurochemical FindingsThe British Journal of Psychiatry, 1979
- INCREASED BRAIN DOPAMINE AND REDUCED GLUTAMIC ACID DECARBOXYLASE AND CHOLINE ACETYL TRANSFERASE ACTIVITY IN SCHIZOPHRENIA AND RELATED PSYCHOSESThe Lancet, 1977
- DOPAMINE AND SCHIZOPHRENIAThe Lancet, 1976
- Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic DrugsScience, 1976
- Central Dopamine Turnover in Schizophrenic SyndromesArchives of General Psychiatry, 1974